ReviewCureus2025
Papillary Thyroid Carcinoma and Its Hormonal Effects in Women Following Surgical Removal.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While typically viewed as indolent, papillary thyroid carcinoma (PTC) is a clinically significant health condition, especially among women, as the primary treatment for PTC, thyroidectomy, and disproportionately affects them. Thyroidectomy disrupts endocrine function, often necessitating a lifetime of hormone replacement therapy, yet postoperative hormonal outcomes remain understudied. PTC's global research trends, post-treatment effects, and treatment methods are the primary focus of this bibliometric analysis, as the growing awareness of PTC and medical drug toxicity continues to stimulate medical research. Bibliometric methods were used to evaluate trends in PTC-related publications from 2016 to 2025, acquiring data from the Web of Science database. The database searched for the following keywords: "papillary thyroid carcinoma", "thyroidectomy", "hormone replacement therapy", and "women's health." Data were downloaded and analyzed using VOSviewer (Leiden University, Leiden, The Netherlands), a bibliometric network creation and visualization software. The qualitative analysis included analysis of co-occurrence of specific keywords in and between publications, common co-authorships, analysis of national collaboration networks, and thematic mapping. Results indicated that the literature primarily focuses on PTC and surgical treatments while neglecting endocrine outcomes, hormonal challenges, and postoperative quality of life. The keywords "surgery" and "management" are widespread, whereas "levothyroxine" and "replacement therapy" are rarely used. Despite the thyroid gland's central position in endocrine control, few studies connect treatment of PTC with any systemic hormonal effects. Moreover, international collaboration is highest between France, the People's Republic of China, and the United States, with the same nations also topping PTC publication figures. A growing interest is shown by the increasing number of publications. Throughout, the bibliometric analysis finds both a notable scarcity of literature on hormonal outcomes in female patients with PTC who have been treated with thyroidectomy and an abundance of surgical literature on common treatment methods for PTC. Unlike existing bibliometric studies, this paper centers on gender-specific consequences and underrepresented endocrine outcomes, offering new insights into long-neglected dimensions of PTC care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.